Angina

Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention (REPTAR)

Targeting Right Ventricle in Pulmonary Hypertension Gilead

Ranolazine for Diabetic Peripheral Neuropathic Pain (DPNP)

Ranolazine and Microvascular Angina by PET in the Emergency Department

Effects of Ranolazine and Exercise on Daily Physical Activity Trial

Ranolazine, Ethnicity and the Metabolic Syndrome

An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)

Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion

Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus

Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus

Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery

Ranolazine and Pulmonary Hypertension

Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine

Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis

Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents

Ranolazine Among Unrevascularized Chronic Stable Angina Patients

The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure

Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine

A Wearable EducAtional Intervention to REduce Angina

Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan